1
|
Lombardo E, Xiong Y, Rabe M, Nierer L, Cusumano D, Placidi L, Boldrini L, Corradini S, Belka C, Riboldi M, Kurz C, Landry G. OC-0043 LSTM networks for real-time respiratory motion prediction for a 0.35 T MR-linac. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02462-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
2
|
Kawula M, Hadi I, Cusumano D, Boldrini L, Placidi L, Corradini S, Belka C, Landry G, Kurz C. PD-0067 AI auto-segmentation for MRgRT of prostate cancer: evaluating 269 MR images from two institutes. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02737-2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
3
|
Xiong Y, Rabe M, Nierer L, Corradini S, Belka C, Riboldi M, Landry G, Kurz C. PD-0227 reconstructing the dosimetric impact of intra-fractional prostate motion in MR-guided radiotherapy. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02782-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
|
4
|
Wang Y, Lombardo E, Zschaek S, Weingärtner J, Holzgreve A, Albert N, Marschner S, Avanzo M, Fanetti G, Franchin G, Stancanello J, Walter F, Corradini S, Niyazi M, Belka C, Riboldi M, Kurz C, Landry G. OC-0460 Deep learning based time to event analysis with PET, CT and joint PET/CT for H&N cancer prognosis. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02596-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
5
|
Rabe M, Palacios M, van Sörnsen de Koste J, Eze C, Hillbrand M, Belka C, Landry G, Senan S, Kurz C. PD-0398 Accumulated dose comparison of stereotactic MRgRT and proton therapy for central lung tumors. Radiother Oncol 2022. [DOI: 10.1016/s0167-8140(22)02833-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/30/2022]
|
6
|
Kurz C. SP-0582 Online CBCT-based proton range and dose calculation. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)08633-3] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
|
7
|
Rogowski P, von Bestenbostel R, Walter F, Straub K, Nierer L, Landry G, Reiner M, Kurz C, Auernhammer C, Belka C, Niyazi M, Corradini S. PO-1235 Feasibility and early clinical experience of online adaptive MR-guided radiotherapy of liver tumors. Radiother Oncol 2021. [DOI: 10.1016/s0167-8140(21)07686-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/20/2022]
|
8
|
Landry G, Kurz C. SP-0511: Improving image quality of CBCT using AI. Radiother Oncol 2020. [DOI: 10.1016/s0167-8140(21)00533-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/26/2022]
|
9
|
Meijers A, Seller OC, Free J, Bondesson D, Seller Oria C, Rabe M, Parodi K, Landry G, Langendijk JA, Both S, Kurz C, Knopf AC. Assessment of range uncertainty in lung-like tissue using a porcine lung phantom and proton radiography. ACTA ACUST UNITED AC 2020; 65:155014. [DOI: 10.1088/1361-6560/ab91db] [Citation(s) in RCA: 12] [Impact Index Per Article: 3.0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/25/2022]
|
10
|
Hager M, Kurz C, Parry JP, Holzer I, Marschalek J, Ott J. Die hysteroskopische Beurteilung der Tubendurchgängigkeit: Ein prospektiver, randomisierter Vergleich zwischen der „Flow“- und der „Parryscope“-Technik. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713193] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- M Hager
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - C Kurz
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - J P Parry
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - I Holzer
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - J Marschalek
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - J Ott
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| |
Collapse
|
11
|
Hager M, Wenzl R, Riesenhuber S, Marschalek J, Kuessel L, Mayrhofer D, Ristl R, Kurz C, Ott J. Die Prävalenz der inzidentiellen Endometriose bei Frauen, die ein laparoskopisches Ovarian Drilling (LOD) wegen Clomiphen-Resistenz bei polyzystischem Ovarsyndrom (PCOS) erhalten: eine retrospektive Kohortenstudie und Meta-Analyse. Geburtshilfe Frauenheilkd 2020. [DOI: 10.1055/s-0040-1713194] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/24/2022] Open
Affiliation(s)
- M Hager
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - R Wenzl
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - S Riesenhuber
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - J Marschalek
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - L Kuessel
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - D Mayrhofer
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - R Ristl
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - C Kurz
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| | - J Ott
- Medizinische Universität Wien, Universitätsklinik für Frauenheilkunde, Klinische Abteilung für Gynäkologische Endokrinologie und Reproduktionsmedizin
| |
Collapse
|
12
|
Chou CW, Collopy AL, Kurz C, Lin Y, Harding ME, Plessow PN, Fortier T, Diddams S, Leibfried D, Leibrandt DR. Frequency-comb spectroscopy on pure quantum states of a single molecular ion. Science 2020; 367:1458-1461. [PMID: 32217722 PMCID: PMC10652508 DOI: 10.1126/science.aba3628] [Citation(s) in RCA: 26] [Impact Index Per Article: 6.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/27/2019] [Accepted: 03/04/2020] [Indexed: 01/21/2023]
Abstract
Spectroscopy is a powerful tool for studying molecules and is commonly performed on large thermal molecular ensembles that are perturbed by motional shifts and interactions with the environment and one another, resulting in convoluted spectra and limited resolution. Here, we use quantum-logic techniques to prepare a trapped molecular ion in a single quantum state, drive terahertz rotational transitions with an optical frequency comb, and read out the final state nondestructively, leaving the molecule ready for further manipulation. We can resolve rotational transitions to 11 significant digits and derive the rotational constant of 40CaH+ to be B R = 142 501 777.9(1.7) kilohertz. Our approach is suited for a wide range of molecular ions, including polyatomics and species relevant for tests of fundamental physics, chemistry, and astrophysics.
Collapse
Affiliation(s)
- C W Chou
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA.
| | - A L Collopy
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
| | - C Kurz
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
| | - Y Lin
- CAS Key Laboratory of Microscale Magnetic Resonance and Department of Modern Physics, University of Science and Technology of China, Hefei 230026, China
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Hefei National Laboratory for Physical Sciences at the Microscale, University of Science and Technology of China, Hefei 230026, China
- Synergetic Innovation Center of Quantum Information and Quantum Physics, University of Science and Technology of China, Hefei 230026, China
| | - M E Harding
- Institute of Nanotechnology, Karlsruhe Institute of Technology (KIT), 76021 Karlsruhe, Germany
| | - P N Plessow
- Institute of Catalysis Research and Technology, Karlsruhe Institute of Technology (KIT), 76021 Karlsruhe, Germany
| | - T Fortier
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - S Diddams
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - D Leibfried
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| | - D R Leibrandt
- Time and Frequency Division, National Institute of Standards and Technology, Boulder, CO 80305, USA
- Department of Physics, University of Colorado, Boulder, CO 80309, USA
| |
Collapse
|
13
|
Kamp F, Liu H, Ermoschkin L, Di Biase M, Kurz C, Landry G, Belka C, Li M. EP-2005 A novel method for rectal wall dose accumulation for prostate cancer patients. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)32425-9] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
14
|
Landry G, Hansen D, Kamp F, Li M, Hoyle B, Weller J, Parodi K, Belka C, Kurz C. OC-0085 Correcting CBCT images for dose calculation using a U-shaped deep convolutional neural network. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30505-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/15/2022]
|
15
|
Kurz C, Maspero M, Savenije M, Landry G, Kamp F, Li M, Parodi K, Belka C, Van den Berg C. OC-0513 Cone-beam CT intensity correction using a generative adversarial network and unpaired training. Radiother Oncol 2019. [DOI: 10.1016/s0167-8140(19)30933-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/17/2022]
|
16
|
Niepel K, Kurz C, Kamp F, Hansen D, Rit S, Neppl S, Hofmaier J, Bondesson D, Thieke C, Dinkel J, Belka C, Parodi K, Landry G. PO-0940: Porcine-lung-phantom based evaluation of proton dose calculations on 4DCBCT. Radiother Oncol 2018. [DOI: 10.1016/s0167-8140(18)31250-7] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/01/2022]
|
17
|
Laxy M, Teuner C, Holle R, Kurz C. The association between BMI and health-related quality of life in the US population: sex, age and ethnicity matters. Int J Obes (Lond) 2017; 42:318-326. [PMID: 28993709 DOI: 10.1038/ijo.2017.252] [Citation(s) in RCA: 33] [Impact Index Per Article: 4.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/16/2017] [Revised: 08/11/2017] [Accepted: 09/03/2017] [Indexed: 01/25/2023]
Abstract
BACKGROUND Obesity is a major public health problem. Detailed knowledge about the relationship between body mass index (BMI) and health-related quality of life (HRQL) is important for deriving effective and cost-effective prevention and weight management strategies. This study aims to describe the sex-, age- and ethnicity-specific association between BMI and HRQL in the US adult population. METHODS Analyses are based on pooled cross-sectional data from 41 459 participants of the Medical Expenditure Panel Survey (MEPS) Household Component (HC) for the years 2000-2003. BMI was calculated using self-reported height and weight, and HRQL was assessed with the EuroQol five-dimensional questionnaire. Generalized additive models were fitted with a smooth function for BMI and a smooth-factor interaction for BMI with sex adjusted for age, ethnicity, poverty, smoking and physical activity. Models were further stratified by age and ethnicity. RESULTS The association between BMI and HRQL is inverse U-shaped with a HRQL high point at a BMI of 22 kg m-2 in women and a HRQL high plateau at BMI values of 22-30 kg m-2 in men. Men aged 50 years and older with a BMI of 29 kg m-2 reported on average five-point higher visual analog scale (VAS) scores than peers with a BMI of 20 kg m-2. The inverse U-shaped association is more pronounced in older people, and the BMI-HRQL relationship differs between ethnicities. In Hispanics, the BMI associated with the highest HRQL is higher than in white people and, in black women, the BMI-HRQL association has an almost linear negative slope. CONCLUSIONS The results show that a more differentiated use of BMI cutoffs in scientific discussions and daily practice is indicated. The findings should be considered in the design of future weight loss and weight management programs.
Collapse
Affiliation(s)
- M Laxy
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, München, Neuherberg, Germany.,German Center for Diabetes Research (DZD), München, Neuherberg, Germany
| | - C Teuner
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, München, Neuherberg, Germany
| | - R Holle
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, München, Neuherberg, Germany.,German Center for Diabetes Research (DZD), München, Neuherberg, Germany
| | - C Kurz
- Institute of Health Economics and Health Care Management, Helmholtz Zentrum München, German Research Center for Environmental Health, München, Neuherberg, Germany
| |
Collapse
|
18
|
Maier W, Kurz C, Präger M, Laxy M. Einbeziehung von Informationen zur adipogenen Umwelt aus Geokodierungsdiensten in die Diabetes-Surveillance: eine Machbarkeitsstudie. Das Gesundheitswesen 2017. [DOI: 10.1055/s-0037-1605651] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022]
Affiliation(s)
- W Maier
- Helmholtz Zentrum München, Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Neuherberg
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg
| | - C Kurz
- Helmholtz Zentrum München, Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Neuherberg
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg
| | - M Präger
- Helmholtz Zentrum München, Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Neuherberg
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg
| | - M Laxy
- Helmholtz Zentrum München, Institut für Gesundheitsökonomie und Management im Gesundheitswesen, Neuherberg
- Deutsches Zentrum für Diabetesforschung (DZD), Neuherberg
| |
Collapse
|
19
|
Hillbrand M, Landry G, Dedes G, Pappas E, Kalaitzakis G, Kurz C, Dörringer F, Kaiser K, Würl M, Englbrecht F, Dietrich O, Makris D, Pappas E, Parodi K. PO-0809: A 3D polymer gel dosimeter coupled to a patient-specific anthropomorphic phantom for proton therapy. Radiother Oncol 2017. [DOI: 10.1016/s0167-8140(17)31246-x] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022]
|
20
|
Göbl C, Ott J, Bozkurt L, Feichtinger M, Rehmann V, Cserjan A, Heinisch M, Steinbrecher H, Just-Kukurova I, Tuskova R, Leutner M, Vytiska-Binstorfer E, Kurz C, Weghofer A, Tura A, Egarter C, Kautzky-Willer A. To assess the association between glucose metabolism and ectopic lipid content in different clinical classifications of PCOS. DIABETOL STOFFWECHS 2016. [DOI: 10.1055/s-0036-1584116] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
|
21
|
Kurz C, Park Y, Kamp F, Rit S, Winey B, Sharp G, Reiner M, Nijhuis R, Hansen D, Ganswindt U, Thieke C, Belka C, Parodi K, Landry G. SU-F-J-186: Enabling Adaptive IMPT with CBCT-Based Dose Recalculation for H&N and Prostate Cancer Patients. Med Phys 2016. [DOI: 10.1118/1.4956094] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
22
|
Gianoli C, De Bernardi E, Kurz C, Riboldi M, Baroni G, Parodi K. Geometrical interpretation of TOF PET raw data in commercial PET-CT scanner for SNR optimization. Radiother Oncol 2016. [DOI: 10.1016/s0167-8140(16)30095-0] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/22/2022]
|
23
|
Kuessel L, Mayerhofer K, Obwegeser R, Kurz C, Husslein H, Nouri K, Helmy S, Wenzl R. Fellowship for Endometriosis. Geburtshilfe Frauenheilkd 2015. [DOI: 10.1055/s-0035-1558385] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022] Open
|
24
|
Ammar C, Frey K, Bauer J, Melzig C, Chiblak S, Hildebrandt M, Unholtz D, Kurz C, Brons S, Debus J, Abdollahi A, Parodi K. Comparing the biological washout of β+-activity induced in mice brain after 12C-ion and proton irradiation. Phys Med Biol 2014; 59:7229-44. [PMID: 25383509 DOI: 10.1088/0031-9155/59/23/7229] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
In clinical ion beam therapy, protons as well as heavier ions such as carbon are used for treatment. For protons, β(+)-emitters are only induced by fragmentation reactions in the target (target fragmentation), whereas for heavy ions, they are additionally induced by fragmentations of the projectile (further referred to as autoactivation). An approach utilizing these processes for treatment verification, by comparing measured Positron Emission Tomography (PET) data to predictions from Monte Carlo simulations, has already been clinically implemented. For an accurate simulation, it is important to consider the biological washout of β(+)-emitters due to vital functions. To date, mathematical expressions for washout have mainly been determined by using radioactive beams of (10)C- and (11)C-ions, both β(+)-emitters, to enhance the counting statistics in the irradiated area. Still, the question of how the choice of projectile (autoactivating or non-autoactivating) influences the washout coefficients, has not been addressed. In this context, an experiment was carried out at the Heidelberg Ion Beam Therapy Center with the purpose of directly comparing irradiation-induced biological washout coefficients in mice for protons and (12)C-ions. To this aim, mice were irradiated in the brain region with protons and (12)C-ions and measured after irradiation with a PET/CT scanner (Siemens Biograph mCT). After an appropriate waiting time, the mice were sacrificed, then irradiated and measured again under similar conditions. The resulting data were processed and fitted numerically to deduce the main washout parameters. Despite the very low PET counting statistics, a consistent difference could be identified between (12)C-ion and proton irradiated mice, with the (12)C data being described best by a two component fit with a combined medium and slow washout fraction of 0.50 ± 0.05 and the proton mice data being described best by a one component fit with only one (slow) washout fraction of 0.73 ± 0.06.
Collapse
Affiliation(s)
- C Ammar
- Ludwig-Maximilians University, Faculty of Physics, Department of Medical Physics, Am Coulombwall 1, 85748 Garching b. Munich, Germany
| | | | | | | | | | | | | | | | | | | | | | | |
Collapse
|
25
|
Schwaab J, Prall M, Sarti C, Kaderka R, Bert C, Kurz C, Parodi K, Günther M, Jenne J. Ultrasound tracking for intra-fractional motion compensation in radiation therapy. Phys Med 2014; 30:578-82. [DOI: 10.1016/j.ejmp.2014.03.003] [Citation(s) in RCA: 23] [Impact Index Per Article: 2.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 01/15/2014] [Revised: 03/06/2014] [Accepted: 03/09/2014] [Indexed: 10/25/2022] Open
|
26
|
Ott J, Walch K, Tempfer CBA, Promberger R, Kurz C, Nouri K. Die schwere Ovarialblutung nach transvaginaler Ovarialpunktion bei IVF: Retrospektive Fallserie und gepoolte Analyse zu Inzidenz, Verlauf und Managment. Geburtshilfe Frauenheilkd 2014. [DOI: 10.1055/s-0034-1374737] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/25/2022] Open
|
27
|
Gianoli C, Baroni G, Bauer J, Kurz C, Parodi K, Riboldi M. 77: Motion compensated reconstructions in PET-based ion beam treatment verification for moving target. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34098-6] [Citation(s) in RCA: 2] [Impact Index Per Article: 0.2] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/28/2022]
|
28
|
Bauer J, Kurz C, Unholtz D, Frey K, Combs S, Debus J, Parodi K. 18: PET/CT-based verification of scanned proton and carbon ion treatment at HIT - an overview. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)34039-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/23/2022]
|
29
|
Gianoli C, Riboldi M, Kurz C, Parodi K, Baroni G. PO-0905: A sinogram warping strategy for pre-reconstruction 4D PET optimization in ion beam therapy application. Radiother Oncol 2014. [DOI: 10.1016/s0167-8140(15)31023-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/25/2022]
|
30
|
Frey K, Bauer J, Unholtz D, Kurz C, Krämer M, Bortfeld T, Parodi K. TPSPET—A TPS-based approach forin vivodose verification with PET in proton therapy. Phys Med Biol 2013; 59:1-21. [DOI: 10.1088/0031-9155/59/1/1] [Citation(s) in RCA: 28] [Impact Index Per Article: 2.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
|
31
|
Bauer J, Unholtz D, Kurz C, Parodi K. An experimental approach to improve the Monte Carlo modelling of offline PET/CT-imaging of positron emitters induced by scanned proton beams. Phys Med Biol 2013; 58:5193-213. [PMID: 23835872 DOI: 10.1088/0031-9155/58/15/5193] [Citation(s) in RCA: 42] [Impact Index Per Article: 3.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/12/2022]
Abstract
We report on the experimental campaign carried out at the Heidelberg Ion-Beam Therapy Center (HIT) to optimize the Monte Carlo (MC) modelling of proton-induced positron-emitter production. The presented experimental strategy constitutes a pragmatic inverse approach to overcome the known uncertainties in the modelling of positron-emitter production due to the lack of reliable cross-section data for the relevant therapeutic energy range. This work is motivated by the clinical implementation of offline PET/CT-based treatment verification at our facility. Here, the irradiation induced tissue activation in the patient is monitored shortly after the treatment delivery by means of a commercial PET/CT scanner and compared to a MC simulated activity expectation, derived under the assumption of a correct treatment delivery. At HIT, the MC particle transport and interaction code FLUKA is used for the simulation of the expected positron-emitter yield. For this particular application, the code is coupled to externally provided cross-section data of several proton-induced reactions. Studying experimentally the positron-emitting radionuclide yield in homogeneous phantoms provides access to the fundamental production channels. Therefore, five different materials have been irradiated by monoenergetic proton pencil beams at various energies and the induced β(+) activity subsequently acquired with a commercial full-ring PET/CT scanner. With the analysis of dynamically reconstructed PET images, we are able to determine separately the spatial distribution of different radionuclide concentrations at the starting time of the PET scan. The laterally integrated radionuclide yields in depth are used to tune the input cross-section data such that the impact of both the physical production and the imaging process on the various positron-emitter yields is reproduced. The resulting cross-section data sets allow to model the absolute level of measured β(+) activity induced in the investigated targets within a few per cent. Moreover, the simulated distal activity fall-off positions, representing the central quantity for treatment monitoring in terms of beam range verification, are found to agree within 0.6 mm with the measurements at different initial beam energies in both homogeneous and heterogeneous targets.
Collapse
Affiliation(s)
- J Bauer
- Heidelberg Ion-Beam Therapy Center, Im Neuenheimer Feld 450, D-69120 Heidelberg, Germany.
| | | | | | | |
Collapse
|
32
|
Aust S, Oshafu Z, Mayerhofer K, Kurz C, Ott J. Hormonelle Charakteristika von infertilen Patientinnen mit Endometriose. Geburtshilfe Frauenheilkd 2013. [DOI: 10.1055/s-0033-1347773] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/26/2022] Open
|
33
|
Frey K, Bauer J, Unholtz D, Kurz C, Kraemer M, Bortfeld T, Parodi K. TH-C-144-06: TPS PET
- A TPS-Based Approach for In-Vivo Dose Verification with PET in Proton Therapy. Med Phys 2013. [DOI: 10.1118/1.4815800] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
34
|
Bauer J, Hildebrandt M, Unholtz D, Kurz C, Parodi K. TH-C-144-12: On the Modelling of Facility-Specific PET Imaging for Proton Treatment Verification: Experimental Validation and Inter-Facility Comparison. Med Phys 2013. [DOI: 10.1118/1.4815806] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
35
|
Parodi K, Bauer J, Kurz C, Unholtz D, Sommerer F, Frey K, Haberer T, Herfarth K, Welzel T, Combs S, Debus J. WE-G-500-06: Offline PET/CT Imaging of Scanned Proton and Carbon Ion Beams: Initial Clinical Experience for Different Tumour Sites. Med Phys 2013. [DOI: 10.1118/1.4815639] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022] Open
|
36
|
Schug M, Huwer J, Kurz C, Müller P, Eschner J. Heralded photonic interaction between distant single ions. Phys Rev Lett 2013; 110:213603. [PMID: 23745873 DOI: 10.1103/physrevlett.110.213603] [Citation(s) in RCA: 3] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Subscribe] [Scholar Register] [Received: 02/27/2013] [Indexed: 06/02/2023]
Abstract
We establish a heralded interaction between two remotely trapped single (40)Ca(+) ions through the exchange of single photons. In the sender ion, we release single photons with a controlled temporal shape on the P(3/2) to D(5/2) transition and transmit them to the distant receiver ion. Individual absorption events in the receiver ion are detected by quantum jumps. For continuously generated photons, the absorption reduces significantly the lifetime of the long-lived D(5/2) state. For triggered single-photon transmission, we observe a coincidence between the emission at the sender and quantum jump events at the receiver.
Collapse
Affiliation(s)
- M Schug
- Universität des Saarlandes, Experimentalphysik, Campus E2 6, 66123 Saarbrücken, Germany.
| | | | | | | | | |
Collapse
|
37
|
Robert C, Dedes G, Battistoni G, Böhlen TT, Buvat I, Cerutti F, Chin MPW, Ferrari A, Gueth P, Kurz C, Lestand L, Mairani A, Montarou G, Nicolini R, Ortega PG, Parodi K, Prezado Y, Sala PR, Sarrut D, Testa E. Distributions of secondary particles in proton and carbon-ion therapy: a comparison between GATE/Geant4 and FLUKA Monte Carlo codes. Phys Med Biol 2013; 58:2879-99. [DOI: 10.1088/0031-9155/58/9/2879] [Citation(s) in RCA: 93] [Impact Index Per Article: 8.5] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
38
|
Barinoff J, Hils R, Bender A, Groß J, Kurz C, Tauchert S, Mann E, Schwidde I, Ipsen B, Sawitzki K, Heitz F, Harter P, Traut A, du Bois A. Clinicopathological differences between breast cancer in patients with primary metastatic disease and those without: a multicentre study. Eur J Cancer 2012; 49:305-11. [PMID: 22940292 DOI: 10.1016/j.ejca.2012.07.027] [Citation(s) in RCA: 17] [Impact Index Per Article: 1.4] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/10/2012] [Revised: 07/17/2012] [Accepted: 07/26/2012] [Indexed: 10/28/2022]
Abstract
OBJECTIVE Approximately 6% of breast cancer (BC) patients present with primary metastatic disease (pmBC) at first diagnosis. The clinicopathological differences between tumours from patients who have metastatic disease and those who do not are unclear. METHODS This study was an exploratory analysis of patients with pmBC treated in 8 German breast cancer centres between 1998 and 2010. Phenotypes were defined using the following immunohistochemical markers: oestrogen receptor (ER), progesterone receptor (PR) and human epidermal growth factor receptor 2 (Her2). The control arm included the group of patients who had neither local recurrence nor distant metastases at a follow-up of at least 30 months after initial diagnosis. RESULTS A total of 2214 patients were included. Of these, 1642 had non metastatic BC, and 572 had pmBC. Eighty-five patients (15%) with pmBC were diagnosed at stage T1. On multivariate analysis, factors associated with pmBC were as follows: positive lymph node status, grade 3, lobular histology and Luminal B phenotype (Her 2 positive). Of the sample, 197 patients (34%) with pmBC were diagnosed as stage T2, 90 patients (16%) were diagnosed as stage T3, and 200 patients (35%) were diagnosed as stage T4. Only positive lymph node status and grade 3 were reported as risk factors for distant metastases in patients with stage T3 and T4 cancer. CONCLUSION There are differences in the clinicopathological features among breast cancer patients with primary metastases and those without. Receptor expression and histological type play a minor role in the risk for metastasis in patients with stage T3 and T4 disease when compared to patients with T1 pmBC tumours. On initial diagnosis, lobular histology and Luminal B positivity (Her 2 positive) in T1 pmBC were determined to be risk factors for primary metastatic disease.
Collapse
|
39
|
Kurz C, Mairani A, Parodi K. First experimental-based characterization of oxygen ion beam depth dose distributions at the Heidelberg Ion-Beam Therapy Center. Phys Med Biol 2012; 57:5017-34. [DOI: 10.1088/0031-9155/57/15/5017] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
40
|
Ott J, Wattar L, Kurz C, Seemann R, Huber JC, Mayerhofer K, Vytiska-Binstorfer E. Parameters for calcium metabolism in women with polycystic ovary syndrome who undergo clomiphene citrate stimulation: a prospective cohort study. Eur J Endocrinol 2012; 166:897-902. [PMID: 22330149 DOI: 10.1530/eje-11-1070] [Citation(s) in RCA: 35] [Impact Index Per Article: 2.9] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 11/08/2022]
Abstract
OBJECTIVE To evaluate whether parameters for calcium metabolism were associated with characteristics of polycystic ovary syndrome (PCOS). DESIGN A prospective cohort study. METHODS Ninety-one anovulatory, infertile women with PCOS patients underwent clomiphene citrate (CC) stimulation. Main outcome measures were parathyroid hormone (PTH); 25-hydroxyvitamin D3 (25OHD3); serum levels of calcium, phosphorus, magnesium, albumin, and total protein; the serum calcium-phosphorus product; LH; FSH; sexual hormone binding globulin; testosterone; and androstenedione. RESULTS PTH correlated inversely with serum calcium (r=-0.235; P=0.004) and 25OHD3 (r=-0.664; P<0.001), whereas positive correlations were found between PTH and body mass index (BMI; r=0.270; P=0.010) and between PTH and testosterone (r=0.347; P=0.001). After stimulation with 50 mg CC, 57.1% (52/91) developed a follicle, whereas 26.4% (24/91) became pregnant. In a multivariate model to predict both follicle development and pregnancy, BMI and 25OHD3 deficiency were significant predictive parameters. CONCLUSIONS 25OHD3 deficiency was an independent predictive parameter of CC stimulation outcome, in terms of follicle development and pregnancy. Our results suggest a substantial role of vitamin D in PCOS and infertility treatment in these patients.
Collapse
Affiliation(s)
- J Ott
- Departments of Gynecologic Endocrinology and Reproductive Medicine, Medical University of Vienna, Waehringer Guertel 18–20, 1090 Vienna, Austria.
| | | | | | | | | | | | | |
Collapse
|
41
|
Bauer J, Unholtz D, Sommerer F, Kurz C, Haberer T, Combs S, Welzel T, Herfarth K, Debus J, Parodi K. PO-0828 FIRST CLINICAL EXPERIENCE WITH OFFLINE PET/CT-BASED IN-VIVO VERIFICATION OF SCANNED CARBON ION IRRADIATION. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71161-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
|
42
|
Seravalli E, Bauer J, Robert C, Stichelbaut F, Kurz C, Smeets J, Schaart D, Buvat I, Parodi K, Verhaegen F. PO-0813 COMPARISON OF MONTE CARLO POSITRON-EMITTER-YIELD CALCULATIONS IN PROTON RADIOTHERAPY. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)71146-5] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
43
|
Seravalli E, Robert C, Bauer J, Stichelbaut F, Kurz C, Smeets J, Van Ngoc Ty C, Schaart DR, Buvat I, Parodi K, Verhaegen F. Monte Carlo calculations of positron emitter yields in proton radiotherapy. Phys Med Biol 2012; 57:1659-73. [PMID: 22398196 DOI: 10.1088/0031-9155/57/6/1659] [Citation(s) in RCA: 57] [Impact Index Per Article: 4.8] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/11/2022]
|
44
|
Parodi K, Bauer J, Frey K, Kurz C, Mairani A, Rinaldi I, Schwaab J, Sommerer F, Unholtz D. 91 EXPERIMENTAL CHARACTERIZATION, MODELING AND IN-VIVO IMAGING TO FOSTER HIGH PRECISION ION BEAM THERAPY AT THE HEIDELBERG ION BEAM THERAPY CENTER. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70067-1] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/27/2022]
|
45
|
Kurz C, Bauer J, Bert C, Bongers A, Jenne J, Richter D, Saito N, Schoenahl F, Unholtz D, Parodi K. 129 FIRST STEPS TOWARDS 4D OFFLINE PET-BASED TREATMENT VERIFICATION AT THE HEIDELBERG ION BEAM THERAPY CENTER. Radiother Oncol 2012. [DOI: 10.1016/s0167-8140(12)70101-9] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/28/2022]
|
46
|
Barinoff J, Hils R, Bender A, Gross J, Kurz C, Tauchert S, Mann E, Schwidde I, Ipsen B, Sawitzki K, Heitz F, Harter P, Traut A, du BA. P4-10-07: Clinico-Pathologic Features of Breast Cancer Patients with Primary Metastatic Disease Versus Localized Disease: A Multicenter Study. Cancer Res 2011. [DOI: 10.1158/0008-5472.sabcs11-p4-10-07] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/16/2022]
Abstract
Abstract
Objective: Approximately 6% of breast cancer patients present with primary metastatic disease (pmBC) at first diagnosis. Clinicopathological differences to non-metastatic patients are undetermined.
Methods: Exploratory analysis of patients with pmBC treated in 8 breast cancer units between 1998 and 2010. Tumor characteristics of these patients were compared with non-metastatic breast cancer patients (BC) of one breast cancer center who had neither local-recurrence nor distant metastases during 30 months of follow-up after first diagnosis. Standard staging in patients with first diagnosis of BC included chest X-ray, abdominal ultrasonography and bone scan. Molecular subtypes were analyzed and defined by immunohistochemical markers (ER, PR, Her2-receptor).
Results: 2.214 patients were included, 1.642 with BC and 572 with pmBC, respectively. Patients with pmBC were 7 years older (BC 58 years of age vs. pmBC 65 years; p=0.000) and were more likely to be postmenopausal (74% vs. 83%; p=0.000). Most common localizations of distant first metastases were bone (61,5%), liver (24%), lung (21%) and non-axillary lymph nodes (12%).
85 (15%) patients with pmBC were diagnosed in stage T1. Factors associated with pmBC in multivariate analysis for this group were positive lymph node status (OR 3.4; 95%CI 2.3−6.0; p=0.000), grading 3 (OR 2.3; 95%CI 1.3−4.0; p=0.003), lobular histology (OR 2.3; 95%CI 1.2−4.5; p=0,010) and phenotype Luminal B (OR 2.4; 95%CI 1.25−5.0; p=0.014). 197 (34%) patients with pmBC were diagnosed in stage T2; positive lymph node status (OR 4.8; 95%CI 1.1−3.0; p=0.017) and grading 3 (OR 1.6; 95% CI 1.6−2.3; p=0.019) were reported as risk factors for this group. 90 (16%) and 200 (35%) patients were diagnosed with stages T3 and T4, respectively. In T3/4 tumors a positive lymph node status (OR 5.2; 95% CI 2.9−9.3; p=0.000) and grading 3 (OR 2.2; 95%CI 1.2−3.9; p=0.009) could be defined as significant risk factors for distant metastases. Postmenopausal status was associated with primary metastases in stage T2 (OR 1.8; 95%CI 1.2−2.9; p=0.008) and T3/4 (OR 2.4; 95%CI 1.2−4.7; p=0.011) but not in T1 tumors (OR 1.3; 95%CI 0.7−2.1; p=0.420). There was no association with hormone or Her2 receptor status nor with a specific phenotype for T2-4 tumors.
Conclusion: The clinico-pathological features of breast cancer patients with or without primary metastases differ. In all stages positive lymph node status and higher grading were associated with pmBC significantly. Lobular histology was reported as a risk factor for T1-2 compared to patients without metastases. This feature was not found for T3/4 pmBC. T1 pmBC were likely to be associated with luminal B phenotype. T3-4 pmBC have not been associated with any phenotype or hormone receptor constellation as risk factor for metastases. Tumor biology seems to play a minor role for risk of metastases in T3-4 stages compared to patients with T1-tumors. Findings from this analysis should be considered in the choice of staging methods, especially in stage T1.
Citation Information: Cancer Res 2011;71(24 Suppl):Abstract nr P4-10-07.
Collapse
Affiliation(s)
- J Barinoff
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - R Hils
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - A Bender
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - J Gross
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - C Kurz
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - S Tauchert
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - E Mann
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - I Schwidde
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - B Ipsen
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - K Sawitzki
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - F Heitz
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - P Harter
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - A Traut
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| | - Bois A du
- 1Kliniken Essen Mitte, Essen, Germany; Dr.-Horst-Schmidt-Klinik, Wiesbaden, Germany; Asklepios Klinik, Lich, Germany; Sankt Gertrauden-Krankenhaus, Berlin-Wilmersdorf, Germany; Klinikum Esslingen, Esslingen am Neckar, Germany; Caritsklinik St. Theresia, Saarbrücken, Germany; Universitätsklinikum Gieβen und Marburg, Standort Marburg, Marburg, Germany; Klinikum Frankfurt Höchst, Frankfurt am Main, Germany; Evangelisches Krankenhaus Wesel, Wesel, Germany
| |
Collapse
|
47
|
Quan P, Pateisky P, Leditznig N, Gaba A, Szabo L, Kurz C, Tschugguel W, Yotova I. Kooperation der Östrogenrezeptoren ERα und ERβ mit GPR30 in der Regulation der östrogeninduzierten ERK-Aktivierung in primären humanen endometrialen Stromazellen. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1286404] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
48
|
Yotova I, Quan P, Gaba A, Leditznig N, Pateisky P, Kurz C, Tschugguel W. Raf-1-Level bestimmen die Migrationsrate von primären endometrialen Stromazellen von Patientinnen mit Endometriose. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1286517] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/17/2022] Open
|
49
|
Ott J, Mayerhofer K, Vytiska-Binstorfer E, Walch K, Huber JC, Kurz C. Intraoperative Androstendion-Kinetik bei Laparoskopischer Ovarialstichelung. Geburtshilfe Frauenheilkd 2011. [DOI: 10.1055/s-0031-1278560] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/18/2022] Open
|
50
|
Wirth S, Kurz C, Nouri K, Mayerhofer K, Huber JC, Ott J. Schwangerschaftsoutcome nach Ovarialstichelung bei Patientinnen mit Polyzystischem Ovarsyndrom. Geburtshilfe Frauenheilkd 2010. [DOI: 10.1055/s-0030-1254986] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/19/2022] Open
|